Don’t Fall for This Cannabis Value Trap

This company has been one of the hardest hit in the sector, but don’t get sucked into a “value trap” by it’s 90% drop.

Short sellers have had a field day with cannabis stocks in 2019 and 2020 after the massive bull market in 2018…

Down 90% from its 2018 highs, Aurora Cannabis Inc. (NYSE: ACB) has been one of the hardest hit companies in the sector.

But don’t get sucked into a “value trap” with this company.

Earlier this year, Aurora shares traded as low as 60 cents from a combination of a low cash balance, a persistently high cash burn rate, and a difficult outlook for raising new capital.

The situation was so dire that the firm had to implement a reverse stock split to maintain its public listing. It also announced a $250 million equity facility that could dilute shareholders by 30%.

Long-term, I do believe it’s only a matter of time before cannabis is federally legal nationwide. And cannabis stocks will certainly be worth more than they are today as a result.

But that time is not now. And it’s probably not even on the horizon for the next five years…

Don’t get me wrong, it’s wonderful to see cannabis stores operating as essential businesses during this pandemic while still being labeled a “Schedule 1” drug by the Federal government.

But at the same time, our country is dealing much more important problems at the moment. And legalizing cannabis may fall behind due to other higher-priority legislation.

20 years from now many cannabis stocks will be worth much more than they are today. But with all the money Aurora Cannabis is burning and only losses to show for it, this business could no longer exist in three to five years…

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works